Eprinomectin in Dogs & Cats
Generic: Eprinomectin
Eprinomectin is a potent, broad-spectrum macrocyclic lactone endectocide used primarily in livestock to control a wide range of internal and external parasites with minimal residue concerns.
This medication is intended for dogs and cats.
Overview
Eprinomectin is a highly specialized member of the avermectin family of parasiticides, distinguished by its unique pharmacokinetic profile that allows for minimal excretion in milk. Unlike Doramectin, which is often utilized for its long-acting properties in beef cattle, eprinomectin is frequently the treatment of choice for dairy cattle because it permits milk to be consumed or sold immediately after application. It represents a significant advancement over older compounds like Morantel, providing superior efficacy against both adult and larval stages of various gastrointestinal nematodes and lungworms. While it shares structural similarities with Moxidectin, eprinomectin is tailored specifically to minimize environmental impact and tissue residue concentrations.
In clinical veterinary practice, the medication is employed to address infestations that threaten herd health, productivity, and weight gain. By targeting the nervous system of susceptible parasites, it disrupts essential physiological processes, leading to paralysis and the eventual death of the target organisms. It is frequently compared in efficacy to Oxibendazole in its ability to clear heavy worm burdens, though its administration method and safety margin in lactating animals give it a distinct market advantage. Practitioners must carefully weigh the cost of treatment against the expected economic return associated with improved animal health and milk production.
While some veterinarians may investigate its use in various species, eprinomectin is predominantly labeled for bovine use. It does not replace niche antiparasitics like Nitenpyram for acute flea control, nor does it serve as a substitute for Pyrantel Pamoate in specific companion animal protocols. When managing multispecies operations, clinicians must be vigilant about species-specific dosing and the potential for off-label toxicity. The drug remains an essential tool in integrated pest management programs, often rotated with other classes of anthelmintics to slow the development of parasite resistance in pasture-based systems.
What It Treats
- Gastrointestinal roundworms (e.g., Ostertagia ostertagi, Haemonchus placei, Trichostrongylus spp.) which cause reduced weight gain and anemia.
- Lungworms (Dictyocaulus viviparus) which cause coughing and respiratory distress.
- Sucking and biting lice (e.g., Linognathus vituli, Bovicola bovis) which cause skin irritation and hide damage.
- Mange mites (e.g., Chorioptes bovis) which lead to crusting skin lesions and intense pruritus.
- Horn flies (Haematobia irritans) which cause significant stress and blood loss.
How It Works
Eprinomectin acts by binding to glutamate-gated chloride channels in the nerve and muscle cells of parasites. This binding significantly increases the permeability of the cell membrane to chloride ions, causing hyperpolarization of the nerve or muscle cell, which leads to flaccid paralysis and the subsequent death or detachment of the parasite from the host. Because mammals lack these specific glutamate-gated chloride channels, the drug has a high margin of safety at recommended doses. The medication is highly lipophilic, allowing it to be absorbed efficiently through the skin and distributed into the bloodstream and tissues where parasites reside. Its selective affinity for the nervous systems of invertebrates ensures that it effectively paralyzes the parasite while remaining relatively inert within the mammalian host's complex metabolic systems.
Dosage
Dosage is strictly calculated based on the animal's body weight, typically administered as a pour-on solution at a rate of 0.5 mg/kg of body weight. It is imperative that producers follow the manufacturer's specific product label and consult with a veterinarian to ensure accuracy, as under-dosing can lead to the development of parasite resistance while over-dosing may increase the risk of toxicity.
Administration
The product is typically administered as a topically applied 'pour-on' solution. The volume of the liquid is poured along the mid-line of the back, extending from the withers to the tailhead. It is vital to ensure the animal is dry at the time of application and remains dry for several hours afterward to ensure maximum absorption into the subcutaneous fat and systemic circulation.
Storage
Store the product in its original, tightly closed container in a cool, dry place, typically between 15°C and 30°C (59°F to 86°F). Keep the medication away from direct sunlight, heat sources, and freezing temperatures. It should be kept out of reach of children and unauthorized personnel, ensuring the container is properly secured to prevent accidental spillage.
Contraindications
Eprinomectin should not be used in animals with known hypersensitivity to macrocyclic lactones. It is also contraindicated for use in species for which it is not labeled, as significant neurological toxicity can occur in dogs and certain other species due to the presence of P-glycoprotein mutations that allow the drug to cross the blood-brain barrier. Additionally, it should not be applied to areas of skin with pre-existing damage, such as mange or lesions, that might cause excessive systemic absorption of the medication. Avoid application to wet hair or during heavy rain, as this may reduce the efficacy of the topical formulation through dilution or runoff.
Interactions
Eprinomectin should be used with caution when administered alongside other drugs that also act as inhibitors of P-glycoprotein, as this can increase the blood concentration of eprinomectin and potentially trigger adverse neurotoxic reactions. Concurrent administration with other macrocyclic lactones is generally contraindicated due to the risk of additive or cumulative toxicity. While specific documented clinical interactions are rare in the approved bovine patient population, clinicians should be cautious when using this drug in conjunction with CNS-depressant medications. Producers should consult their veterinarian before applying any other topical agents to the same site of application to ensure that drug absorption and efficacy are not compromised.
Side Effects
- Mild transient skin irritation at the site of application
- Ataxia (loss of coordination) in cases of accidental overdose
- Muscle tremors
- Mydriasis (dilated pupils)
- Depression or lethargy
Sources & References
Frequently Asked Questions
This information is educational only and not a substitute for professional veterinary advice. Always consult a licensed veterinarian before starting or changing any medication.
